NCT01151020

TX2® Low Profile TAA Endovascular Graft

Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 110 (actual)
• Sponsor: Cook Research Incorporated · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The Zenith® TX2® Low Profile TAA Endovascular Graft study is a clinical trial approved by US FDA to evaluate the safety and effectiveness of the Zenith® TX2® Low Profile TAA Endovascular Graft indicated for the treatment of patients with aneurysms/ulcers of the descending thoracic aorta having vessel structure suitable for repair.

Conditions

• Aortic Aneurysm
• Penetrating Ulcer
• Vascular Disease

Interventions

Type	Name	Description
DEVICE	Zenith® TX2® Low Profile TAA Endovascular Graft	Endovascular treatment of patients with aneurysms/ulcers of the descending thoracic aorta having morphology suitable for endovascular repair

Timeline

• Start date: 2010-03-01
• Primary completion: 2014-01-01
• Completion: 2018-05-11
• First posted: 2010-06-25
• Last updated: 2021-01-22
• Results posted: 2016-02-29

Locations

33 sites across 6 countries: United States, Germany, Italy, Japan, Sweden, United Kingdom